APA (7th ed.) Citation

Xu, J., Fang, K., Li, X., Han, L., Sun, S., & Sun, T. (2025). From residual risk to precision intervention: The evolving role of minimal residual disease in breast cancer management. Cancer Biology & Medicine, 22(12), 1493. https://doi.org/10.20892/j.issn.2095-3941.2025.0431

Chicago Style (17th ed.) Citation

Xu, Junnan, Kun Fang, Xiaoxi Li, Li Han, Shulan Sun, and Tao Sun. "From Residual Risk to Precision Intervention: The Evolving Role of Minimal Residual Disease in Breast Cancer Management." Cancer Biology & Medicine 22, no. 12 (2025): 1493. https://doi.org/10.20892/j.issn.2095-3941.2025.0431.

MLA (9th ed.) Citation

Xu, Junnan, et al. "From Residual Risk to Precision Intervention: The Evolving Role of Minimal Residual Disease in Breast Cancer Management." Cancer Biology & Medicine, vol. 22, no. 12, 2025, p. 1493, https://doi.org/10.20892/j.issn.2095-3941.2025.0431.